Leading pharmaceutical firms criticized for passive legal action

Published: 2012-03-12 07:00:00

Updated: 2012-03-12 07:00:00

The domestic leading pharmaceutical firms are under fire for their tepid attitude over legal action against the government’s plan to slash insured drug prices in April.

Dalim Biotech and KMS Pharma filed a legal suit against the Health Ministry for the massive price-cut measures on Wednesday.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK